Procter & Gamble Company (The) $PG Holdings Cut by Crossmark Global Holdings Inc.

Crossmark Global Holdings Inc. lessened its stake in shares of Procter & Gamble Company (The) (NYSE:PG) by 2.0% during the third quarter, HoldingsChannel.com reports. The fund owned 211,935 shares of the company’s stock after selling 4,405 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Procter & Gamble were worth $30,790,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in the stock. Baxter Bros Inc. purchased a new stake in Procter & Gamble during the 2nd quarter valued at $12,381,000. Empowered Funds LLC bought a new position in shares of Procter & Gamble during the 2nd quarter valued at $53,549,000. Bank of America Corp DE purchased a new position in shares of Procter & Gamble in the 2nd quarter worth $3,850,628,000. Rokos Capital Management LLP purchased a new position in shares of Procter & Gamble in the 1st quarter worth $29,914,000. Finally, State Street Corp grew its holdings in shares of Procter & Gamble by 1.0% in the second quarter. State Street Corp now owns 102,216,308 shares of the company’s stock worth $14,988,999,000 after acquiring an additional 965,461 shares during the period. 65.77% of the stock is currently owned by institutional investors.

Procter & Gamble Stock Down 1.5%

PG opened at $156.97 on Thursday. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.47 and a current ratio of 0.68. Procter & Gamble Company has a fifty-two week low of $137.62 and a fifty-two week high of $167.25. The firm’s fifty day moving average is $147.65 and its 200 day moving average is $146.83. The stock has a market cap of $364.58 billion, a price-to-earnings ratio of 23.71, a price-to-earnings-growth ratio of 3.96 and a beta of 0.39.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings results on Wednesday, July 29th. The company reported $1.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.41 by $0.02. Procter & Gamble had a return on equity of 31.36% and a net margin of 18.44%. The business had revenue of $21.20 billion during the quarter, compared to analyst estimates of $21.38 billion. During the same quarter in the prior year, the business posted $1.48 EPS. Procter & Gamble’s revenue for the quarter was up 1.5% compared to the same quarter last year. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. On average, sell-side analysts forecast that Procter & Gamble Company will post 6.98 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be given a $1.0885 dividend. This represents a $4.35 annualized dividend and a dividend yield of 2.8%. The ex-dividend date is Friday, October 23rd. Procter & Gamble’s payout ratio is presently 65.71%.

Insider Transactions at Procter & Gamble

In other news, CFO Andre Schulten sold 3,914 shares of the company’s stock in a transaction dated Monday, October 5th. The stock was sold at an average price of $145.34, for a total value of $568,860.76. Following the completion of the transaction, the chief financial officer owned 65,618 shares of the company’s stock, valued at $9,536,920.12. This represents a 5.63% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Paul Gama sold 2,225 shares of the stock in a transaction dated Monday, October 5th. The stock was sold at an average price of $145.34, for a total value of $323,381.50. Following the sale, the chief executive officer owned 51,124 shares of the company’s stock, valued at $7,430,362.16. This represents a 4.17% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders have sold 15,135 shares of company stock valued at $2,189,970. 0.23% of the stock is owned by corporate insiders.

More Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Procter & Gamble’s dividend remains a key support for the stock. The company recently recorded its 70th consecutive annual dividend increase, reinforcing its appeal to income-focused investors, particularly while interest rates remain elevated. The Ultimate Dividend Growth Stock to Buy With $100 Right Now
• Positive Sentiment: Royal Bank of Canada reaffirmed its “outperform” rating and maintained a $166 price target, implying additional upside from the referenced trading level. Benzinga analyst-rating report
• Neutral Sentiment: Investors are comparing PG’s dependable profitability and cash flow from essential household products with higher-risk consumer brands such as Nike. This supports PG’s defensive profile but does not provide a new earnings catalyst. Nike vs. Procter & Gamble
• Negative Sentiment: Procter & Gamble expects only 1% to 3% organic sales growth, raising concerns that the company’s large brands may be struggling to generate stronger underlying demand. Procter & Gamble Expects 1% to 3% Organic Growth
• Negative Sentiment: The earnings preview identifies a central risk: recovering product volumes could be offset by pricing headwinds, potentially limiting revenue growth and margins. Procter & Gamble Earnings Preview
• Negative Sentiment: Options-market activity indicates traders are positioned for PG shares to decline following the earnings release, reflecting elevated near-term uncertainty. Barchart Earnings Analysis

Wall Street Analysts Forecast Growth

PG has been the subject of a number of research reports. BMO Capital Markets upped their price objective on Procter & Gamble from $169.00 to $170.00 and gave the company an “outperform” rating in a research report on Monday, June 29th. HSBC reissued a “hold” rating and issued a $149.00 target price (down from $182.00) on shares of Procter & Gamble in a report on Thursday, July 30th. Bank of America dropped their target price on Procter & Gamble from $170.00 to $166.00 and set a “buy” rating on the stock in a research report on Friday, July 10th. UBS Group restated a “buy” rating on shares of Procter & Gamble in a research note on Friday, October 16th. Finally, TD Cowen reaffirmed a “hold” rating and set a $150.00 price target on shares of Procter & Gamble in a research report on Wednesday, September 30th. Fourteen investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $162.20.

About Procter & Gamble

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.